Medtronic, AngioScore Challenge Abbott’s Attempt To Extend Catheter Patent
This article was originally published in The Gray Sheet
Executive Summary
Device firms Medtronic and AngioScore are fighting an effort by Abbott to extend the life of its valuable "rapid-exchange" catheter patent, set to expire Oct. 29
You may also be interested in...
Patent Face-Off: FDA Denial Isn’t The End Of Rapid-Exchange Dispute
FDA has denied a citizen petition seeking to derail Abbott's efforts to extend its rapid-exchange delivery patent for the Xience V drug-eluting stent, but the petitioner says that was all according to plan
Patent Face-Off: FDA Denial Isn’t The End Of Rapid-Exchange Dispute
FDA has denied a citizen petition seeking to derail Abbott's efforts to extend its rapid-exchange delivery patent for the Xience V drug-eluting stent, but the petitioner says that was all according to plan
Rapid Exchange In Cardiac Cath Space: Medtronic Launches, Abbott Sues
Medtronic finally reentered the U.S. market with popular rapid-exchange (RX) coronary catheter delivery systems Oct. 30 after an eight-year absence, prompting an immediate patent infringement suit from Abbott